🇺🇸 FDA
Patent

US 6514982

CRF receptor antagonists and methods relating thereto

expired A61PA61P25/00A61P25/08

Quick answer

US patent 6514982 (CRF receptor antagonists and methods relating thereto) held by Neurocrine Biosciences, Inc. expires Mon Jan 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue Feb 04 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61P, A61P25/00, A61P25/08, A61P25/18, A61P25/24